153 related articles for article (PubMed ID: 37653012)
1. [Development and Validation of A Prognostic Nomogram to Guide Decision-making
in Lung Large Cell Neuroendocrine Carcinoma].
Chen S; Li S; Wang Z; Zhang W; Zhou L; Jiao W
Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):487-496. PubMed ID: 37653012
[TBL] [Abstract][Full Text] [Related]
2. Risk factors, survival analysis, and nomograms for distant metastasis in patients with primary pulmonary large cell neuroendocrine carcinoma: A population-based study.
Song Z; Zou L
Front Endocrinol (Lausanne); 2022; 13():973091. PubMed ID: 36329892
[TBL] [Abstract][Full Text] [Related]
3. Prognostic nomogram predicts overall survival in pulmonary large cell neuroendocrine carcinoma.
He Y; Liu H; Wang S; Chen Y
PLoS One; 2019; 14(9):e0223275. PubMed ID: 31560723
[TBL] [Abstract][Full Text] [Related]
4. Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer.
Huang L; Feng Y; Xie T; Zhu H; Tang L; Shi Y
BMC Cancer; 2023 Apr; 23(1):312. PubMed ID: 37020179
[TBL] [Abstract][Full Text] [Related]
5. Treatment outcome and prognostic analysis of advanced large cell neuroendocrine carcinoma of the lung.
Xia L; Wang L; Zhou Z; Han S
Sci Rep; 2022 Oct; 12(1):16562. PubMed ID: 36195623
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a nomogram for predicting the overall survival of patients with lung large cell neuroendocrine carcinoma.
Xi J; Zhao M; Zheng Y; Liang J; Hu Z; Huang Y; Yang Y; Zhan C; Jiang W; Lu T; Guo W; Wang Q
Transl Cancer Res; 2020 Aug; 9(8):4943-4957. PubMed ID: 35117856
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and nomogram for pulmonary resected high-grade neuroendocrine carcinomas: a 20-year single institutional real-world experience.
Liu L; Zhang J; Zhao K; Guo C; Huang C; Li S; Chen Y
Orphanet J Rare Dis; 2024 Jun; 19(1):232. PubMed ID: 38863016
[TBL] [Abstract][Full Text] [Related]
8. Construction and application of dynamic online nomogram for prognosis prediction of patients with advanced (Stage III/IV) tongue squamous cell carcinoma.
Qin Z; Hu Z; Huang B; Wang F; Pan H; He X; Yin L
J Stomatol Oral Maxillofac Surg; 2023 Oct; 124(5):101477. PubMed ID: 37080357
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and prognostic factors for pulmonary large cell neuroendocrine carcinoma with brain metastasis.
Chen X; Huang Y; Chen F; She H; Chen X
Cancer Med; 2023 Feb; 12(4):4087-4099. PubMed ID: 36125491
[TBL] [Abstract][Full Text] [Related]
10. Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.
Diao JD; Wu CJ; Cui HX; Bu MW; Yue D; Wang X; Liu YL; Yang YJ
Medicine (Baltimore); 2019 Nov; 98(46):e17916. PubMed ID: 31725640
[TBL] [Abstract][Full Text] [Related]
11. Metastasis pattern and prognosis of large cell neuroendocrine carcinoma: a population-based study.
Jiang T; Sun H; Li N; Jiang T
J Cancer Res Clin Oncol; 2023 Nov; 149(15):13511-13521. PubMed ID: 37498395
[TBL] [Abstract][Full Text] [Related]
12. The nomograms for predicting overall and cancer-specific survival in elderly patients with early-stage lung cancer: A population-based study using SEER database.
Yu G; Liu X; Li Y; Zhang Y; Yan R; Zhu L; Wang Z
Front Public Health; 2022; 10():946299. PubMed ID: 36159305
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a nomogram for predicting overall survival of resected N2 non-small cell lung cancer patients undergoing neoadjuvant radiotherapy.
Shi J; Peng B; Wang C; Zhou X; Lu T; Xu R; Chang X; Shen Z; Wang K; Xu C; Zhang L
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11779-11790. PubMed ID: 37407846
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
[TBL] [Abstract][Full Text] [Related]
15. Construction and Validation of Prognosis Nomogram for Metastatic Lung Squamous Cell Carcinoma: A Population-Based Study.
Liu Y; Sun M; Xiong Y; Gu X; Zhang K; Liu L
Technol Cancer Res Treat; 2022; 21():15330338221132035. PubMed ID: 36217877
[No Abstract] [Full Text] [Related]
16. Prognostic Nomogram for Overall Survival in Small Cell Lung Cancer Patients Treated with Chemotherapy: A SEER-Based Retrospective Cohort Study.
Liang M; Chen M; Singh S; Singh S
Adv Ther; 2022 Jan; 39(1):346-359. PubMed ID: 34729705
[TBL] [Abstract][Full Text] [Related]
17. A Clinical Nomogram for Predicting Cancer-Specific Survival in Pulmonary Large-Cell Neuroendocrine Carcinoma Patients: A Population-Based Study.
Ma H; Xu Z; Zhou R; Liu Y; Zhu Y; Chang X; Chen Y; Zhang H
Int J Gen Med; 2021; 14():7299-7310. PubMed ID: 34737624
[TBL] [Abstract][Full Text] [Related]
18. Prognostic nomograms for lung neuroendocrine carcinomas based on lymph node ratio: a SEER database analysis.
Xiong L; Jiang Y; Hu T
J Int Med Res; 2022 Sep; 50(9):3000605221115160. PubMed ID: 36076355
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a prognostic nomogram for predicting overall survival in patients with primary bladder sarcoma: a SEER-based retrospective study.
Li S; Liu X; Chen X
BMC Urol; 2021 Nov; 21(1):162. PubMed ID: 34823525
[TBL] [Abstract][Full Text] [Related]
20. Construction and validation of prognostic nomograms for elderly patients with metastatic non-small cell lung cancer.
Sun H; Liu M; Yang X; Ren Y; Dai H; Wang C
Clin Respir J; 2022 May; 16(5):380-393. PubMed ID: 35514033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]